Skip to main content
OpenTrials

Clinical trial condition

Gastroesophageal Junction Carcinoma (GEJC)

Explore clinical trials studying Gastroesophageal Junction Carcinoma (GEJC). Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies
Refine in advanced search Browse all conditions

Gastroesophageal Junction Carcinoma (GEJC) trial results

Completed

Study of Pembrolizumab (MK-3475) Versus Placebo in Participants With Esophageal Carcinoma Who Are Receiving Chemotherapy and Radiation Therapy (MK-3475-975/KEYNOTE-975)

NCT04210115

Conditions
Adenocarcinoma Of Esophagus, Carcinoma, Carcinoma, Squamous Cell, +17 more
Locations
  • MemorialCare Health System - Long Beach Medical Center-Oncology ( Site 0691) Long Beach, California, United States
  • Columbus Regional Research Institute ( Site 0047) Columbus, Georgia, United States
  • University of Kansas Cancer Center ( Site 0023) Westwood, Kansas, United States
  • Cancer Center of Kansas ( Site 0058) Wichita, Kansas, United States
View all 170 locations
View Trial Details

Related conditions